Ipca Laboratories today reported a standalone net profit of Rs 65.52 crore for the quarter ended June 30, mainly on account of robust sales.
The drug firm had posted a net loss of Rs 20.25 crore in the year-ago period, Ipca Labs said in a BSE filing.
Total income stood at Rs 867.56 crore for the quarter under review. It was Rs 719.14 crore for the same period a year ago.
"Indian formulations income was up 36 per cent at Rs 400.94 crore," the company said.
Shares of Ipca Laboratories were trading at Rs 789 per scrip on BSE, down 0.72 per cent from the previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)